SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 86 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2014. The put-call ratio across all filers is 3.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $107,000 | -2.7% | 62,947 | 0.0% | 0.03% | -5.6% |
| Q2 2018 | $110,000 | -4.3% | 62,947 | 0.0% | 0.04% | -16.3% |
| Q1 2018 | $115,000 | -17.9% | 62,947 | 0.0% | 0.04% | -10.4% |
| Q4 2017 | $140,000 | -23.5% | 62,947 | 0.0% | 0.05% | -27.3% |
| Q3 2017 | $183,000 | -34.6% | 62,947 | 0.0% | 0.07% | -36.5% |
| Q2 2017 | $280,000 | -4.4% | 62,947 | 0.0% | 0.10% | -5.5% |
| Q1 2017 | $293,000 | -23.5% | 62,947 | 0.0% | 0.11% | -29.5% |
| Q4 2016 | $383,000 | +10.4% | 62,947 | 0.0% | 0.16% | +6.8% |
| Q3 2016 | $347,000 | +45.2% | 62,947 | 0.0% | 0.15% | +46.0% |
| Q2 2016 | $239,000 | +37.4% | 62,947 | 0.0% | 0.10% | +29.9% |
| Q1 2016 | $174,000 | +480.0% | 62,947 | +481.3% | 0.08% | +492.3% |
| Q3 2014 | $30,000 | -31.8% | 10,829 | 0.0% | 0.01% | -35.0% |
| Q2 2014 | $44,000 | – | 10,829 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,009,984 | $16,683,000 | 6.50% |
| DAFNA Capital Management LLC | 317,563 | $2,636,000 | 2.23% |
| Trellus Management Company, LLC | 162,900 | $1,352,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 246,250 | $2,246,000 | 1.15% |
| WALL STREET ASSOCIATES | 861,200 | $7,148,000 | 0.67% |
| EAM Investors, LLC | 670,346 | $5,564,000 | 0.65% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 200,000 | $1,660,000 | 0.58% |
| CARL DOMINO INC | 66,900 | $555,000 | 0.38% |
| Belmont Global Advisors, Inc. | 36,200 | $300,000 | 0.33% |
| Lombard Odier Asset Management (USA) Corp | 507,223 | $4,210,000 | 0.30% |